1. COVID-19 and β-thalassemia: in lieu of evidence and vague nexus.
- Author
-
Al-Kuraishy, Hayder M., Mazhar Ashour, Mohamed H., Saad, Hebatallah M., and Batiha, Gaber El-Saber
- Subjects
- *
COVID-19 , *IRON overload , *CORONAVIRUS diseases , *COMMUNICABLE diseases , *BLOOD transfusion reaction , *SARS-CoV-2 , *CORONAVIRUSES - Abstract
Coronavirus disease 19 (COVID-19) is an infectious disease caused by severe acute respiratory coronavirus 2 (SARS-CoV-2) causing acute systemic disorders and multi-organ damage. β-thalassemia (β-T) is an autosomal recessive disorder leading to the development of anemia. β-T may lead to complications such as immunological disorders, iron overload, oxidative stress, and endocrinopathy. β-T and associated complications may increase the risk of SARS-CoV-2, as inflammatory disturbances and oxidative stress disorders are linked with COVID-19. Therefore, the objective of the present review was to elucidate the potential link between β-T and COVID-19 regarding the underlying comorbidities. The present review showed that most of the β-T patients with COVID-19 revealed mild to moderate clinical features, and β-T may not be linked with Covid-19 severity. Though patients with transfusion-dependent β-T (TDT) develop less COVID-19 severity compared to non-transfusion-depend β-T(NTDT), preclinical and clinical studies are recommended in this regard. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF